Evidence map›Paper›PMID 42383371›Full record

ArticleBriefings in functional genomics2026

Multi-view knowledge-guided flow subgraphs with substructure initialization for explainable DDI prediction.

Yugui Xu, Zhigan Zhou, Hao Yuan, Siqi Liu, Quan Zou, Yongqing Zhang, Wenqian Zhang

Abstract read
In one paragraph

Article in Briefings in functional genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yugui XuSchool of Computer Science, Chengdu University of Information Technology, No. 24 Block 1, Xuefu Road, Chengdu, 610225, China.
Zhigan ZhouSchool of Computer Science, Chengdu University of Information Technology, No. 24 Block 1, Xuefu Road, Chengdu, 610225, China.
Hao YuanSchool of Computer Science, Chengdu University of Information Technology, No. 24 Block 1, Xuefu Road, Chengdu, 610225, China.
Siqi LiuSchool of Computer Science, Chengdu University of Information Technology, No. 24 Block 1, Xuefu Road, Chengdu, 610225, China.
Quan ZouInstitute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, No. 2006, Xiyuan Ave, West Hi-Tech Zone, Chengdu 611731, China.
Yongqing ZhangSchool of Computer Science, Chengdu University of Information Technology, No. 24 Block 1, Xuefu Road, Chengdu, 610225, China.
Wenqian ZhangDepartment of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, XiYuan Campus, 5 Jingyuan Road, Shijingshan District, Beijing, 100043, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polypharmacy has become essential in managing complex and chronic conditions, yet it introduces significant clinical risks due to potential drug-drug interactions (DDIs). Existing computational models struggle to provide accurate and interpretable predictions, largely due to fragmented integration of molecular structures and biomedical knowledge. These limitations arise from static graph designs, inadequate substructure modeling, and insufficient incorporation of semantic context, highlighting the need for a unified, explainable solution. In this study, we propose MKGFlow-DDI, a multi-view knowledge-guided framework that jointly leverages drug-drug interaction networks and biomedical knowledge graphs to dynamically construct drug-flow subgraphs. The model incorporates a dual-channel encoder designed to capture atom-level information and substructure-level features, integrating them with the global semantic embeddings of the composite network to derive novel feature representations. These representations are fused to initialize node features within each subgraph, which are iteratively optimized through similarity-based edge refinement to reduce noise and enhance biological relevance. To further improve generalization and stability, a contrastive learning module is introduced to align representations of perturbed subgraphs by maximizing consistency across positive and negative sample pairs. Experimental results on DrugBank and TWOSIDES demonstrate that MKGFlow-DDI outperforms state-of-the-art baselines, especially in scenarios involving previously unseen drugs. Additionally, the model produces interpretable semantic pathways that align with known pharmacological mechanisms, enabling clinically meaningful insights. Overall, MKGFlow-DDI establishes a robust and biologically grounded approach to DDI prediction, offering a promising direction for computational pharmacovigilance and personalized therapy optimization.

Indexed as

Drug InteractionsModels, ChemicalAlgorithmscontrastive learningdrug–drug interactiongraph neural networksmulti-view knowledge

Identifiers

PMID42383371
PMCPMC13320273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.